研究実績

A multicenter phase II trial of perioperative capecitabine plus oxaliplatin for clinical stage III gastric cancer (OGSG1601)

Ryohei Kawabata, Tetsuji Terazawa, Jin Matsuyama, Shunji Endo, Osamu Shiraishi, Shoichiro Fujita, Yusuke Akamaru, Hirokazu Taniguchi, Mitsutoshi Tatsumi, Masahiro Goto, Sang-Woong Lee, Yoshitaka Kurisu, Yukinori Kurokawa, Toshio Shimokawa, Daisuke Sakai, Takeshi Kato, Kazumasa Fujitani, Taroh Satoh  ESMO 2018, Munich, 19 – 23 Oct 2018

前の記事 次の記事 一覧ページへ戻る